Psoriasis and comorbid diseases: epidemiology

J Takeshita, S Grewal, SM Langan, NN Mehta… - Journal of the American …, 2017 - Elsevier
Psoriasis is a common chronic inflammatory disease of the skin that is increasingly being
recognized as a systemic inflammatory disorder. Psoriatic arthritis is a well-known …

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

CA Elmets, CL Leonardi, DMR Davis… - Journal of the American …, 2019 - Elsevier
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with
awareness and attention to comorbidities - ScienceDirect Skip to main contentSkip to article …

Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

SA Hasni, S Gupta, M Davis, E Poncio… - Nature …, 2021 - nature.com
Increased risk of premature cardiovascular disease (CVD) is well recognized in systemic
lupus erythematosus (SLE). Aberrant type I-Interferon (IFN)-neutrophil interactions contribute …

Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week

MS Garshick, NL Ward, JG Krueger… - Journal of the American …, 2021 - jacc.org
Psoriasis is a chronic inflammatory skin disease that affects 2% to 3% of the US population.
The immune response in psoriasis includes enhanced activation of T cells and myeloid …

Psoriasis and major adverse cardiovascular events: a systematic review and meta‐analysis of observational studies

EJ Armstrong, CT Harskamp… - Journal of the American …, 2013 - Am Heart Assoc
Background Psoriasis is a chronic inflammatory disease that may be associated with
increased risk of cardiovascular events, including cardiovascular mortality, myocardial …

Psoriasis and cardiovascular risk: a comprehensive review

W Masson, M Lobo, G Molinero - Advances in therapy, 2020 - Springer
Psoriasis is a systemic inflammatory disorder that involves complex pathogenic interactions
between the innate and adaptive immune systems. Individuals with psoriasis have an …

Psoriasis and comorbid diseases: Implications for management

J Takeshita, S Grewal, SM Langan, NN Mehta… - Journal of the American …, 2017 - Elsevier
As summarized in the first article in this continuing medical education series, the currently
available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic …

[HTML][HTML] The effect of inflammation and infection on lipids and lipoproteins

KR Feingold, C Grunfeld - Endotext [internet], 2022 - ncbi.nlm.nih.gov
Chronic inflammatory diseases, such as rheumatoid arthritis (RA), systemic lupus
erythematosus (SLE), and psoriasis and infections, such as periodontal disease and HIV …

Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities

C Ryan, B Kirby - Dermatologic clinics, 2015 - derm.theclinics.com
Once considered to be solely a cutaneous disease, there is now robust evidence that
psoriasis is associated with systemic inflammation and a significantly increased risk of …

A phase IV, randomized, double-blind, placebo-controlled crossover study of the effects of ustekinumab on vascular inflammation in psoriasis (the VIP-U trial)

JM Gelfand, DB Shin, A Alavi, DA Torigian… - Journal of Investigative …, 2020 - Elsevier
Psoriasis is a T helper type 17 autoimmune disease associated with an increased risk
cardiovascular events and mortality. Ustekinumab, an antibody to p40, blocks cytokines IL …